Nanoco Group PLC Welcomes MEPs' Rejection of Cadmium Quantum Dots (8094N)
May 20 2015 - 8:31AM
UK Regulatory
TIDMNANO
RNS Number : 8094N
Nanoco Group PLC
20 May 2015
For immediate release 20 May 2015
NANOCO GROUP PLC
("Nanoco" or the "Company")
Welcomes MEPs' Rejection of Cadmium in Quantum Dots
Nanoco Group plc (LSE: NANO), a world leader in the development
and manufacture of cadmium-free quantum dots and other
nanomaterials, confirms that Members of the European Parliament
("MEPs") have voted against a proposed extension of an exemption to
the Restriction of Hazardous Substances Directive (RoHS) which
would have allowed the use of cadmium-containing quantum dots in
Europe.
Nanoco welcomes this decision by MEPs owing to the threat posed
by cadmium to human health and to the environment.
Michael Edelman, Nanoco's Chief Executive Officer, said: "We are
very pleased by this decision by the European Parliament and we
would like to thank MEPs for the time they have taken to understand
the detail and implications of the proposed exemption.
"Cadmium-free quantum dots are without question the preferred
choice for human and environmental health. Such quantum dots have
significant technological benefits and they are available today. We
look forward to their increasingly widespread use throughout
Europe, and worldwide, in multiple applications including enhanced
LCD displays."
For further information, please contact:
Nanoco Tel: +44 (0) 161
603 7900
Michael Edelman, Chief Executive
Officer
Mark Sullivan, Interim Chief
Financial Officer
Canaccord Genuity - Joint Broker Tel: +44 (0) 20
7523 8000
Simon Bridges
Cameron Duncan
Mark Whitmore
Liberum - Joint Broker Tel: +44 (0) 20
3100 2000
Simon Atkinson
Richard Bootle
Buchanan Tel: +44 (0) 20
7466 5000
Mark Court / Sophie Cowles
/ Stephanie Watson
Notes for editors:
About Nanoco Group plc
Nanoco is a world leader in the development and production of
cadmium-free quantum dots and other nanomaterials for use in
multiple applications including LCD displays, lighting, solar cells
and bio-imaging. In the display market, it has an exclusive
manufacturing and marketing licensing agreement with The Dow
Chemical Company.
Nanoco was founded in 2001 and is headquartered in Manchester,
UK. It has production facilities in Runcorn, UK, and a US
subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has
business development executives in Japan, Korea and Taiwan. Its
technology is protected worldwide by a large and growing patent
estate.
Nanoco is listed on the main market of the London Stock Exchange
and trades under the ticker symbol NANO. For further information
please visit: www.nanocotechnologies.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFFVESIIFIE
Nanoco (LSE:NANO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nanoco (LSE:NANO)
Historical Stock Chart
From Apr 2023 to Apr 2024